Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies
暂无分享，去创建一个
P. Angenendt | F. Meric-Bernstam | R. Kurzrock | F. Janku | A. Naing | D. Hong | J. Wheler | Kevin B. Kim | S. Piha-Paul | A. Tsimberidou | M. Overman | A. Bedikian | R. Luthra | R. Zinner | G. Falchook | F. Diehl | S. Fu | E. S. Kopetz | B. Kee | Veronica R. Holley | G. Cabrilo | E. Kopetz